gesunheitpfleges.org



Preclinical study results for Syk, JAK inhibitor program presented at ASH 2010

September 15, 2015

Presenter: Jan Burger, M.D., Ph.D., MD Anderson Cancer CenterPoster Session: CLL - Biology and Pathophysiology, excluding Therapy: Poster III  Date: Monday, December 6, 6:00 - 8:00 p.m. ET Location: Hall A3/A4 (Orange County Convention Center) Poster Board III-383

Sub-Optimal Inhibition of Thrombus Formation by Aspirin (as measured by RTTP analysis) in Primary Thrombocythemia

Presenter: Gillian Stephens, Ph.D., Portola PharmaceuticalsPoster Session: Pathophysiology of Thrombosis: Poster IIDate: Monday, December 6, 6:00 - 8:00 p.m. ETLocation: Hall A3/A4 (Orange County Convention Center) Poster Board III-997

SOURCE Portola Pharmaceuticals, Inc.